JACN Did you know that you can get alerts when a new issue is online?
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Szamosi, T.
Right arrow Articles by Szabo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Szamosi, T.
Right arrow Articles by Szabo, T.
Journal of the American College of Nutrition, Vol. 23, No. 5, 386-390 (2004)
Published by the American College of Nutrition

Hyperhomocysteinemia, Enzyme Polymorphism and Thiobarbituric Acid Reactive System in Children with High Coronary Risk Family History

Tamas Szamosi, MD, PhD, FACN, Erzsebet Roth, MD, PhD, Tamas Szamosi, Jr, MD, Erika Tomsits, MD, PhD, Attila Tordai, MD and Terez Szabo, MD, PhD

2nd Department of Pediatrics, Medical Faculty, Semmelweis University (T.S., E.T.), Budapest, HUNGARY
Department of Research Surgery, Medical Faculty, University of Pecs (E.R.), Budapest, HUNGARY
National Health Center (T.S.Jr., A.T.), Budapest, HUNGARY
Department of Clinical Pathology, Heim Pal Children’s Hospital (T.S.), Budapest, HUNGARY

Address reprint requests to: Tamas Szamosi, M.D., Ph.D., 2nd Department of Pediatrics, Med. Fac. Semmelweis Univ., Tüzoltó u. 7, H-1094 Budapest, HUNGARY. E-mail: szatam{at}gyer2.sote.hu

Objectives: To investigate both the frequency and the genetic background of hyperhomocysteinemia and the frequency of increased plasma thiobarbituric acid reactive system (TBARS) levels in children and adolescents whose parents had premature coronary heart disease (CHD).

Methods: The study was performed on children and adolescents aged 4–18 years (105 offspring of parents with CHD before age 45 and 74 referents from families without any evidence of premature atherosclerosis). Fasting serum total cholesterol (TC), high density lipoprotein cholesterol (HDL-C), and total triglyceride (TG) levels were measured by enzymatic methods. Low density lipoprotein cholesterol (LDL-C) level was calculated by the Friedewald formula. Plasma total homocysteine (THCy) level was measured by fluorescence polarisation immunoassay. Plasma TBARS level was determined by fluorimetric method. 5,10-methylenetetrahydrofolate reductase (MTHFR) enzyme polymorphism was analyzed by polymerase chain reaction with restriction fragment length polymorphism (PCR-RFLP).

Results: Hyperhomocysteinemia was found in 32 cases and in 4 controls. Increased plasma THCy level was found in 10 children and adolescents from 12 cases homozygous for the C677T polymorphism of the MTHFR gene. No similar high frequency was observed in heterozygous subjects. Elevated fasting plasma TBARS levels were found in 38 cases and in 8 controls. The frequency differences were significant (p < 0.01). Allele frequency of the MTHFR polymorphism among cases and controls was similar. Significant correlation (r = 0.53, p < 0.02) was detected between plasma THCy and TBARS levels. One child had high serum TC level, 5 had low serum HDL-C level and all other children had normal serum TC, LDL-C, HDL-C and TG levels from children with hyperhomocysteinemia and/or high plasma TBARS levels. A significant correlation (r = 0.64, p < 0.01) was observed between plasma THCy levels of parents and children in the case group.

Conclusion: The measurement of plasma THCy and TBARS levels may contribute to the detection of the risk of children and adolescents with high CHD risk family history.

Key words: plasma total homocysteine, plasma TBARS, children, parents, CHD






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the American College of Nutrition.